Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haploidentical HSCT for Thalassemia Major
NCT03171831Phase 4Unknown
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Apr 2017
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial in beta thalassemia major, sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoint: Overall Survival at 2 years. Status: unknown.
02
Conditions
beta thalassemia major
Beyond the preview
Go deeper on NCT03171831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03171831.